|
Treatment of Pediatric Primary LymphedemaGuenter Klose, MLD/CDT Certified Instructor, CLT-LANA
The hereditary lymphedemas can be subdivided into two types:
Type I is referred to as Nonne-Milroy Syndrome (Milroy’s disease). In
this type of familial, congenital lymphedema, the innate defect of the
lymphatic system appears in the lower part of the body in the form of
aplastic lymph vessels (aplasia = defective development or congenital
absence). Pathology: Primary lymphatic dysplasia can be present in a variety of anomalies. For example: hypoplasia of lymph vessels – the number of lymph vessels is reduced and the diameter of the existing lymph vessels is smaller than normal (most common form); hyperplasia of lymph vessels (lymphangiectasia) – the lymph vessels are bigger than normal and have insufficient valve function; aplasia (absence) of single lymph vessels2 or lymph capillaries3 - lymph node hypoplasia combined with fibrosis and groin lymphadenopathy (Kinmonth Syndrome). Any of these changes will reduce the transport capacity of the lymphatic system. Lymphedema arises when the transport capacity is not sufficient to remove the normal amount of proteins and water from the interstitium4. Diagnosis and Differential Diagnosis: Since primary lymphedema can be combined with other congenital anomalies and/or general angiodysplasias (malformation of blood as well as lymph vessel tissue), an expert physician assessment is important to identify all medical issues before treatment begins. The clinical diagnosis of primary lymphedema can usually be established without invasive (and expensive) testing. Lymphangioscintigraphy (LAS) is a lymphatic function test and can be used to confirm the diagnosis of primary lymphedema. With the results of the LAS, the expert physician or radiologist will be able to draw conclusions about the function of the remaining, poorly developed, or damaged peripheral lymphatic system. In combined angiodysplasias, this test is required to assess the magnitude of lymphatic impairment. In uncomplicated extremity lymphedema with a typical medical history, the outcome of the LAS usually does not provide information that would change the treatment options for the patient. Also, if the patient decides or the parents of a small child with lymphedema decide to have Complete Decongestive Therapy (CDT) to treat the lymphedema, the results of the LAS usually will not influence the treatment protocol. Ultrasound, Venous Doppler, Computer Tomography (CT scan), or Magnetic Resonance Imaging (MRI) are diagnostic tests that generally are not required in primary lymphedema of the extremities2. These tests may be ordered by expert physicians in more complicated (combined) lymphedemas to subsequently provide safe treatment for each patient. Therapy: Since lymphedema is a chronic and progressive condition, the patient faces a lifelong medical problem. When a child is born with lymphedema, the entire family is concerned. Treatment should be initiated as soon as possible but only after a thorough medical evaluation has been performed. Complete Decongestive Therapy (CDT): In CDT for small children, the focus of the treatment should be the education and training of the parents or other adult primary caregiver. The child also should be involved in the training. For example, the responsibility for the home maintenance program should be taught to the child in accordance with chronological and psychosocial guidelines5. The initial treatment sessions with a CDT certified therapist may be approached by making the child’s acquaintance (playing) and by teaching basic strokes of Manual Lymph Drainage (MLD), such as stationary circles and effleurage (in the direction of the normal lymph transport) to the primary caregiver. These MLD techniques can then be performed as often as necessary in short sessions even when the child is playing or sleeping. The frequency and duration of each session should be determined by the following parameters: the effectiveness of MLD must not be compromised, tolerance of the child, level of commitment of the primary caregiver (burnout!) etc. Special techniques such as fibrous tissue techniques (manual techniques used to soften indurated, proliferated connective tissue) should be used only by qualified therapists. After an initial series of approximately 10 to 15 sessions, the treatment should be the responsibility of the primary caregiver. The progress of these home treatments should be monitored continuously by a CDT trained and certified therapist or knowledgeable physician. Bandaging is indicated in most cases of primary lymphedema. A common
problem in bandaging is the small size of the extremity and the pressure
sensitivity of the delicate baby skin. The CDT therapist will have to
be somewhat creative and tolerant when applying the first bandages. Padding
materials are required to avoid pressure sores, blisters and irritations
of the skin. Velfoam (material used in rehabilitation) often replaces
the bulky conventional foam and provides adequate protection. The pressure
exerted by the bandage has to be introduced gently and is increased over
a comfortable period of time. Caution: Overeager parents and therapists sometimes
must be reminded that the purpose of the bandage is to raise the compromised
tissue pressure in lymphedema and that the bandage must never be used
to "squeeze" the limb. Bandaging too vigorously may have an adverse effect
on the lymphedema! In addition, it can cause tourniquet effects, or further
compromise the already reduced transport of the lymph vessels. Bandaging
may be the only way to restore the diminished tissue pressure after edema
fluid has been evacuated through the techniques of MLD. Occasionally,
it may be a good idea to give the child a rest and stop bandaging to avoid
burnout! If swelling recurs, this normally can be controlled with the
next MLD and bandaging session. For optimal compliance, the bandage has
to be applied in a way that will not interfere with normal childhood activities
(play) and development. Progress may be halted by the occurrence of spontaneous
infections (cellulitis) or normal childhood diseases such as influenza,
chickenpox, etc. The application of compression garments is often very difficult or even impossible during the first few years of life. It is realistic to assume that the first garment can be tolerated when the child reaches the age of two. These garments must be custom-made for each child. Flat-knitted fabrics such as the JOBST Elvarex®, JUZO Helastic® or JUZO Strong® seems to be the most effective and comfortable products. Measuring and fitting for such small garments often create a big challenge for the therapist. Compression class I (18-21 mm/Hg), or class II (25-32 mm/Hg) should be sufficient in most cases. Keeping in mind that the ease of donning and the tolerance of the child will determine the compliance with wearing the garment. After the initial decongestion has been achieved and the child is transitioned
into the home care phase, the TributeTM sleeve may be considered
as an alternative to the compression bandaging at night. Skin care is very important because skin has a tendency to become dry with the frequent use of bandages and/or garments. Mycosis of the foot (athlete’s foot), eczema, or contact dermatitis need to be addressed if they occur. Exercise is an important component of CDT. For small children with lymphedema, no special exercise program is required as long as the child is otherwise developing normally. Should a special pediatric exercise program be necessary for conditions other than the lymphedema, it is the therapist’s responsibility to work this into the daily routine and advise the primary caregiver accordingly. Ancillary problems such as weight control, the avoidance of tight clothing and temperature extremes should also be observed by the young lymphedema patient. In addition, any orthopedic and postural problems which may exist must be treated. In the case of lower extremity lymphedema, consultation with an orthopedic specialist is advisable. Splayfoot, which may lead to pain in the area of the metatarsal, often is observed in patients with lymphedema (one study reports that in a group of 50 randomly chosen patients with lower extremity primary lymphedema ranging from 13 to 70 years of age, 45 (90%) developed splayfoot in the swollen extremity2). Compression Pumps: Mechanical drainage via a multi-chambered, sequential compression pump is usually not effective and any results achieved are short-lived. Problems with the use of the compression pump are numerous and are not discussed in this article. In the past, only a small number of individuals reported good results when using the pump. Nevertheless, whenever a pump is used, a knowledgeable lymphedema therapist or physician should monitor the patient frequently and check the adjacent trunk and genital areas for edema. FlexitouchTM Therapy: This relatively new, mechanical therapy device (which looks like a compression pump) attempts to mimic the movements of MLD in an effort to facilitate lymphatic drainage. Using this device may ease the burden of the primary care giver, however, its long-term effectiveness is not yet established. Currently the FelexitouchTM is only available for adults or adolescents, not for small children. Surgery: Surgical interventions are often discussed for lymphedema. There is no safe or reliable surgical treatment available which restores the reduced transport capacity in primary extremity lymphedema. Resection (debulking) procedures introduce much scarring and the long-term results are often very unsatisfactory. Lymphatic surgery is sometimes necessary, but should be reserved for special cases, e.g. chylous or other reflux syndromes. Genetics and Lymphangiogenisis: In recent years, researchers have been able to link some of the hereditary forms of primary lymphedemas to particular chromosomes (genes)6. In addition, Lymphangiogenisis (the growing of new lymphatic vessels) is been investigated as future treatment of lymphedema. Nevertheless, more time and research will be necessary in order to gain a therapeutic benefit from these studies. Conclusion: Primary (congenital) lymphedema is a chronic, progressive condition that deserves serious medical attention. A cure for lymphedema is not available, but a patient or parent who follows the recommended program of CDT as part of a daily routine will find great relief from the symptoms. With good adherence, the patient will be less prone to developing serious complications (infections) and, most importantly, avoid the progression of the lymphedema.
|
|||||||||||||||
SITEMAP copyright © 2006/2007 Circle of Hope Lymphedema Foundation Inc. nonprofit 501(c) (3) 36 Woodcrest Drive Prospect, Connecticut 06712 U.S.A. email: JTLymphedema@aol.com :: Phone/Fax 203-758-6138 :: site : prospectpcweb.com |
||||||||||||||||